A recent study published in Small addresses the persistent difficulty of treating refractory melanoma, an aggressive form of skin cancer that often does not respond to existing therapies.
Although diagnostic tools and immunotherapies have improved in recent years, a substantial number of patients remain unresponsive to current treatment options, highlighting the need for alternative therapeutic approaches.
Image Credit: New Africa/Shutterstock.com
The researchers in this study explore a strategy that combines intracellular stress targeting with immune modulation.
Specifically, they investigate the co-administration of two hydrophobic drugs: copper diethyldithiocarbamate (CuET), which inhibits the p97-UFD1-NPL4 protein complex to induce endoplasmic reticulum (ER) stress and promote cytotoxicity; and 6-bromo-indirubin-3′-oxime (BIO), a GSK3 inhibitor that can influence inflammatory pathways and tumor cell growth.
Background
Melanoma becomes particularly difficult to treat once it develops resistance to standard therapies. Tumor cells can avoid immune detection and resist cell death mechanisms, reducing the effectiveness of many treatments. This study focuses on targeting both cellular stress pathways and immune checkpoints as a dual approach.
CuET disrupts protein degradation by inhibiting the p97-UFD1-NPL4 complex, leading to ER stress and apoptosis, especially in cancer cells already under stress. BIO, as a GSK3 inhibitor, affects β-catenin signaling and the production of inflammatory cytokines, which can help reshape the tumor microenvironment to enhance immune recognition.
Because both CuET and BIO are hydrophobic, systemic delivery is a challenge. To address this, the researchers developed liposome-polymer nanoparticles (LPNs) capable of encapsulating the drugs, improving their solubility, delivery precision, and release control.
The Current Study
The research included both in vitro and in vivo experiments to evaluate the drug delivery system. The team first established the optimal molar ratio of CuET to BIO using several melanoma cell lines, including B16F10 and YUMM1.7, along with their variants.
The drugs were co-loaded into LPNs made from phospholipids and stabilized with poly(vinylpyrrolidone), which improved their compatibility in aqueous environments. Particle size, surface charge, encapsulation efficiency, and stability were analyzed using dynamic light scattering and electron microscopy.
Cellular uptake and cytotoxicity were assessed using viability assays (including the sulforhodamine B method) in both two-dimensional cell cultures and three-dimensional tumor spheroids. Additional analyses (such as immunofluorescence, Western blotting, and flow cytometry) were used to track changes in β-catenin levels, immune marker expression, and T cell activation.
In vivo, the LPNs were tested in mouse models of melanoma, again using the B16F10 and YUMM1.7 cell lines, which exhibit features of therapy-resistant disease. Tumor growth, metastasis, and treatment-related toxicity were monitored through imaging, histological evaluation, and blood analysis.
Results and Discussion
The co-loaded nanoparticles demonstrated consistent particle size (100–150 nm), high encapsulation efficiency, and stability under physiological conditions. In vitro, the combination therapy showed a greater reduction in melanoma cell viability than either drug alone, indicating a synergistic cytotoxic effect.
One notable finding was BIO’s ability to counteract the accumulation of β-catenin induced by CuET. This suggests that the drug pair can modulate intracellular signaling in a way that may limit tumor proliferation and reduce metastatic potential. The combination also increased markers of ER stress and apoptosis, supporting the idea that the two drugs operate through complementary mechanisms.
Beyond direct effects on tumor cells, the study also examined the immune-related impact of the treatment. The combination therapy led to reduced expression of PD-L1 on tumor cells, potentially improving immune cell recognition. Flow cytometry revealed increased levels of immune activation markers such as CD69, along with changes in PD-1 expression on T cells. CuET alone increased PD-1 levels, a response that was moderated by the addition of BIO.
CuET was also found to suppress IL-2 secretion from activated T cells, directly influencing immune cell function. These results suggest that the therapy engages both tumor-intrinsic and immune-modulatory pathways, contributing to a more comprehensive anti-tumor response.
In vivo, treatment with the liposome-polymer nanoparticles led to a significant decrease in tumor size—about 47 % in B16F10 models and over 75 % in YUMM1.7 models. Importantly, this effect was achieved without significant toxicity. Mice maintained stable body weight, and blood and histological analyses showed no signs of liver or kidney damage.
Overall, the findings support the use of this nanocarrier system for delivering hydrophobic drug combinations, offering effective tumor suppression with a favorable safety profile.
Conclusion
This study presents a liposome-polymer nanoparticle system designed to deliver CuET and BIO in combination as a potential treatment for resistant melanoma. The formulation demonstrated stability, effective tumor suppression in vitro and in vivo, and a favorable safety profile.
By targeting ER stress, β-catenin signaling, and immune checkpoint pathways, the approach offers a multi-faceted therapeutic option for melanoma that has not responded to existing treatments.
Further research may explore the use of similar delivery systems for other drug combinations, particularly in cancers where treatment resistance remains a significant challenge.
Journal Reference
Paun R. A., et al. (2025). Liposome-Polymer Nanoparticles Loaded with Copper Diethyldithiocarbamate and 6-Bromo-Indirubin-3′-Oxime Enable the Treatment of Refractive Melanoma. Small, DOI: 10.1002/smll.202409012, https://onlinelibrary.wiley.com/doi/10.1002/smll.202409012
News
Researcher at Russian plague laboratory dies of ‘unknown’ infection
Russian authorities have imposed "anti-epidemic measures" after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. The researcher, a 28-year-old female [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
A Surprising Brain Signal Could Explain Why Eating Less Protein Extends Lifespan
A new paper suggests that limiting protein intake triggers a coordinated response throughout the body that may help explain how protein restriction affects healthy aging. Animals respond to protein restriction, or reduced protein in [...]
Back and shoulder surgery is often worse than useless
Millions of operations should be scrapped SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on [...]
Cocaine plays with mind, hijacks brain circuit, drives increasingly rigid and repetitive behavior
Researchers have found that cocaine hijacks brain circuit, which to drive increasingly rigid and repetitive behavior. The brain circuit that normally participates in selecting natural mouth and face movements, but which becomes disproportionately engaged [...]
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a median survival of just 12-15 months, even with the best available care. Now, researchers at the [...]
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences [...]
West African scientists warn of weakening health systems and urge stronger outbreak detection
LOME, Togo (AP) — West African laboratory scientists called on governments Friday to strengthen capacity to detect disease outbreaks to avoid another major outbreak, saying health systems across the region are becoming weaker. Participants [...]
A Little-Known Protein Could Point to a New Way To Treat Alzheimer’s
A study suggests that increasing SORLA protein levels could help treat Alzheimer’s disease and other disorders involving tau protein. Increasing SORLA, a protein with a protective role in the brain, helped mice withstand damage [...]
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
